Optimizing Patient Outcomes - New Primary Therapy Options for Stage III-IV Hodgkin Lymphoma |
1.00 |
04/24/2025 - 12:00am to 11/16/2025 - 12:00am |
Refining Therapeutic Approaches in Relapsed/Refractory Multiple Myeloma: Expert Guidance on Bispecific Antibody Therapy Optimization |
1.00 |
04/11/2025 - 12:00am to 04/11/2026 - 12:00am |
NCCN Guidelines® Insights - Testicular Cancer, Version 2.2025 |
1.00 |
04/10/2025 - 12:00am to 04/10/2026 - 12:00am |
Recorded Presentations from the NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium |
|
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Biomarker Testing and Interpretation after Breast Cancer Diagnosis |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Neoadjuvant/Adjuvant Treatment of Early-Stage Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Updates to Radiation Therapy for Invasive Breast Cancer with SABCS Updates |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Surgical Management of DCIS and Invasive Breast Cancer with SABCS Updates |
0.50 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Management of CNS Metastases in Patients with Breast Cancer |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Advances in the Management of Metastatic Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Inequities in Clinical Outcomes in Breast Cancer: Do Biologic Differences Based on Ancestry/Racial Identity Play a Role? |
0.50 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Survivorship Care for Patients Living with Metastatic Breast Cancer |
1.00 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma |
1.00 |
03/14/2025 - 12:00am to 08/17/2025 - 12:00am |
NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer |
1.00 |
03/14/2025 - 12:00am to 08/31/2025 - 12:00am |
Recorded Presentation from Optimizing Patient Outcomes - Beyond the Package Insert: Appropriate Interpretation of Testing Results for Targeted... |
1.00 |
03/10/2025 - 12:00am to 03/10/2026 - 12:00am |